Anticoagulation

Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al

Read time: 18m 10s
ACC.24 Late-breaking Science Preview

Listen time: 28m 10s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Minh That Ton , Tri Huynh Quang Ho , Viet Lan Nguyen , et al

Read time: 18m

Tri Huynh Quang Ho , Minh That Ton , Viet Lan Nguyen , et al

Read time: 18m
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 36s

Kerry Layne , Albert Ferro ,

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Julia Sikorska , James Uprichard ,

Mario Petretta , Pierluigi Costanzo , Alberto Cuocolo ,

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Watch time: 4h 13m 20s (28 videos)

John JV McMurray, Mirvat Alasnag, Purvi Parwani, et al

Watch time: 4h 49m 46s (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Watch time: 3h 30m 28s (17 videos)

Frédéric Michard ,

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Media

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s

Robert F Storey, Dominick J Angiolillo, Christopher P Cannon, et al

Watch time: 1h 32m 8s (5 videos)

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 1h 35m 42s (16 videos)
ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
ESC 23: The PUSH-AHF Study

Paulus Kirchhof,

Watch time: 3m 42s

Yugo Yamashita,

Diana Gorog, Sotiris Antoniou , Franco Cheng, et al

Watch time: 59m 32s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Media

ESC 23: MULTISTARS AMI Trial

Linda Joosten,

Watch time: 4m 9s
View from the Thoraxcenter: What's Hot at ACC.24?

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 28m 9s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s
View from the Thoraxcenter: AHA 23 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 23m 13s

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s
Dr Steven Lubitz

Watch time: 5m 24s

Yugo Yamashita,

Marco Valgimigli, Diana Gorog, Eliano Navarese, et al

Felicita Andreotti, Diana Gorog, Marco Valgimigli, et al

Watch time: 1h 30m 44s
CardioNerds @AHA23: AZALEA-TIMI 71: Abelcibab Vs Rivaroxaban in Patients with AF

Naima Maqsood, Christian Ruff,

Watch time: 10m 36s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia,

Watch time: 7m 20s

Articles

New Anticoagulants as an Alternative to Aspirin in Atrial Fibrillation

Raffaele De Caterina

,

Citation:

European Cardiology 2011;7(3):196–8

DOI:

https://doi.org/10.15420/ecr.2011.7.3.196
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1143
  • Downloads: Downloads 2

Stroke Prevention in Atrial Fibrillation - The Unmet Need and Morbidity Burden

A John Camm

,

Citation:

European Cardiology 2011;7(3):187–95

DOI:

https://doi.org/10.15420/ecr.2011.7.3.187
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1553
  • Downloads: Downloads 10
  • Citations: 1

Platelet Function Testing in Clinical Practice - Experience and Views from Europe and the US

Thomas O Bergmeijer

,

Jochem Wouter van Werkum

,

Udaya S Tantry

,

Paul A Gurbel

,

Jur ten Berg

,

Citation:

European Cardiology 2011;7(3):203–11

DOI:

https://doi.org/10.15420/ecr.2011.7.3.203
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 440
  • Downloads: Downloads 8
  • Citations: 1

New Drugs for Thromboembolic Prevention in Atrial Fibrillation

Jose L Merino

,

José López-Sendón

,

Citation:

European Cardiology 2010;6(4):64–9

DOI:

https://doi.org/10.15420/ecr.2010.6.4.64
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 598
  • Downloads: Downloads 5